Correlation Between Hanesbrands and OWC Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Hanesbrands and OWC Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hanesbrands and OWC Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hanesbrands and OWC Pharmaceutical Research, you can compare the effects of market volatilities on Hanesbrands and OWC Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hanesbrands with a short position of OWC Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hanesbrands and OWC Pharmaceutical.

Diversification Opportunities for Hanesbrands and OWC Pharmaceutical

0.15

Correlation Coefficient

Hanesbrands  OWC Pharmaceutical

Average diversification

The 3 months correlation between Hanesbrands and OWC is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Hanesbrands and OWC Pharmaceutical Research in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OWC Pharmaceutical and Hanesbrands is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hanesbrands are associated (or correlated) with OWC Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OWC Pharmaceutical has no effect on the direction of Hanesbrands i.e., Hanesbrands and OWC Pharmaceutical go up and down completely randomly.

Pair Corralation between Hanesbrands and OWC Pharmaceutical

Considering the 90-day investment horizon Hanesbrands is expected to generate 0.25 times more return on investment than OWC Pharmaceutical. However, Hanesbrands is 4.0 times less risky than OWC Pharmaceutical. It trades about -0.15 of its potential returns per unit of risk. OWC Pharmaceutical Research is currently generating about -0.13 per unit of risk. If you would invest  812.00  in Hanesbrands on December 29, 2024 and sell it today you would lose (225.00) from holding Hanesbrands or give up 27.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Hanesbrands  vs.  OWC Pharmaceutical Research

Hanesbrands

Risk-Adjusted Performance

Very Weak

Over the last 90 days Hanesbrands has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

OWC Pharmaceutical

Risk-Adjusted Performance

Very Weak

Over the last 90 days OWC Pharmaceutical Research has generated negative risk-adjusted returns adding no value to investors with long positions. Even with fragile performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Hanesbrands and OWC Pharmaceutical

The main advantage of trading using opposite Hanesbrands and OWC Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hanesbrands position performs unexpectedly, OWC Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OWC Pharmaceutical will offset losses from the drop in OWC Pharmaceutical's long position.

The idea behind Hanesbrands and OWC Pharmaceutical Research pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.